Development of a business case for a macrofilaricide used in treatment and control of onchocerciasis

MMGH supported the Bill & Melinda Gates Foundation in assessing the public health and financial viability of a macrofilaricide drug to accelerate the elimination of onchocerciasis. MMGH coordinated the definition of potential use cases, worked with modellers from the Imperial College London and the Erasmus University Rotterdam to assess its epidemiological and economic impact, assessed the regulatory, product development and drug delivery strategy, and assembled the overall business case.